Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report

INTRODUCTION: In about 15% to 20% of breast cancer cases, human epidermal growth factor receptor 2 (HER2) over-expression or gene-amplification is associated with poor prognosis. Thanks to the development of target therapies, HER2 positive patients can be managed using HER2-targeting drugs. There ar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Yue, Li, Wentao, Liu, Xin, Zhang, Jingjing, Huang, Xiaoyan, Zhang, Na, Fu, Tonghui, Ma, Dalin, Li
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2020
Matèries:
3500
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7748359/
https://ncbi.nlm.nih.gov/pubmed/33371069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000023406
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars